Penicillium marneffei is an AIDS-defining endemic mycosis in Southeast Asia. Patients usually present with fever, weight loss, mucocutaneous lesions, lymphadenopathy, hepatomegaly, or pulmonary infiltrates. 1 We hereby report the first case of asymptomatic P. marneffei fungemia in an HIVinfected patient.
A 47-year-old male was admitted on July 6, 2002 for one week's history of dyspnea. He had been receiving isoniazid, rifampin, pyrazinamide, and ethambutol for three months for treatment of disseminated tuberculosis affecting the lung, terminal ileum, mesenteric lymph nodes, and peritoneum (key clinical and laboratory findings are summarized in Table 1 ). On admission, he was hypoxic with a temperature of 37.8 8C. There were fine crepitations over bilateral lung bases and a chest radiograph showed bilateral ground-glass infiltrates. Cultures of sputum, bronchoalveolar lavage, and blood were all negative for bacteria and acid-fast bacilli, but transbronchial biopsy confirmed Pneumocystis jiroveci pneumonitis. No fungal pathogens were seen in the sections or bronchoalveolar lavage. Serology for HIV-1 was positive by enzyme-linked immunosorbent and Western blot assays. His CD4+ T-lymphocyte count was 81 cells/mL with a viral load of 100 000 copies/mL. The pneumonitis responded well to two weeks of cotrimoxazole, and he was discharged completely asymptomatic. However, a blood culture taken on the first day of this admission (BACTEC Myco/F Lytic culture bottle, BACTEC 9000, Becton-Dickinson, Maryland, USA), intended for detection of mycobacteria in blood, was positive for a fungus five weeks later. Subcultures on Sabouraud agar showed thermal dimorphism with yeast-like colonies and mould form at 37 8C and 25 8C, respectively. A diffusible red pigment was noted in the mould culture, which was characteristic of P. marneffei ( Figure 1 ). There were no mucocutaneous lesions, lymphadenopathy, or hepatosplenomegaly at any time. Repeated chest radiographs showed marked improvement without any hilar shadows. Repeated blood cultures were negative. Despite the negative physical findings, oral itraconazole 200 mg twice daily was given for two weeks followed by 200 mg daily for maintenance. The patient did not develop overt penicilliosis in the following 34 months.
Penicilliosis is a potentially fatal opportunistic infection in AIDS patients and its classical manifestations have been described. 1 However, our patient has several notable features that are different from the previously reported cases. Firstly, he remained asymptomatic despite the episode of documented fungemia. The isolation of P. marneffei should be considered as genuine fungemia as the fungus has never been known to cause contamination of blood cultures. Secondly, the fungemia appeared to be transient as the fungus was not isolated from the patient again even before the antifungal agent was given. Asymptomatic fungal infections have been reported in patients with pulmonary cryptococcosis and paracoccidioidomycosis. 2, 3 This case suggests that transient asymptomatic P. marneffei fungemia is also possible. From a previously reported serological study, there could be a significant number of clinically asymptomatic individuals infected with P. marneffei, particularly among those living in endemic areas. 4 Similarly, an immunocompromised patient with Waldenström's macroglobulinemia developed mixed Candida tropicalis and P. marnef-
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Letters to the Editor Started antiretroviral treatment with indinavir, ritonavir, and combivir fei fungemia during hospitalization, pointing to the possibility of reactivation of a latent infection. 5 We postulate that in HIVinfected patients, asymptomatic P. marneffei infection could have occurred earlier in life and the fungus may remain latent thereafter. As the course of HIV infection progresses and the patient becomes increasingly immunocompromised, or when immunosuppressing diseases occur in HIV-negative patients, the latent infection may develop into overt penicilliosis. HIV patients living in, or those with a history of traveling to areas where P. marneffei is endemic should ideally be tested for previous exposure to the fungus and primary antifungal prophylaxis be considered. Unfortunately, there are currently no good tests available for this purpose, and seropositivity alone cannot differentiate past infection from latency. A positive fungal culture, even in the absence of the typical manifestations of penicilliosis, should be considered as clinically significant and antifungal treatment and/or prophylaxis should be considered. Further studies would be required to prove that antifungal prophylaxis is beneficial in preventing the development of overt penicilliosis from latent infections.
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Pseudomonas infection of implantable cardioverter-defibrillator generator and leads as a complication of gastrostomy
A 59-year-old Caucasian male with a history of coronary artery disease, severe chronic obstructive pulmonary disease, heart failure, bladder and prostate carcinoma, and an implanted cardioverter-defibrillator (ICD), was referred to our institution for further treatment of an infected ICD pocket. An ICD was implanted in an abdominal pocket in 1993 and had been changed three times since due to lead fracture or battery dysfunction. The third placement was in the left pectoral region 18 months prior to admission. Six weeks prior to admission, the patient was admitted to a local hospital with acute bronchitis. A percutaneous endoscopic gastrostomy (PEG) tube was placed due to aspiration, medial to the old ICD abdominal pocket. Shortly after, a Letters to the Editor Figure 1 Penicillium marneffei isolated from the patient's blood. Panel A shows the septated hyphae first found in the blood culture after five weeks. Panel B shows the distinctive diffusible red pigment from the mould when subcultured at room temperature on Sabouraud agar.
